Yibai Pharmaceutical (600594.SH): Compound Cantharidin Capsules and others are likely to be selected for centralized procurement.

According to the report from Zhitong Finance APP, Yibai Pharmaceutical (600594.SH) announced that it recently participated in the bidding for the national traditional Chinese medicine procurement alliance centralized procurement (second batch continuation). As per the notice issued by the National Traditional Chinese Medicine Joint Procurement Office regarding the announcement of the supply list for the selected products in the centralized procurement of the national traditional Chinese medicine procurement alliance, the company's products, Compound Banzhilu Capsules and Ginkgo Biloba Injection, have been selected for this continuation procurement.